BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6151597)

  • 21. Improved determination of betaxolol in biological samples by capillary column gas chromatography.
    Ganansia J; Gillet G; Padovani P; Bianchetti G
    J Chromatogr; 1983 Jun; 275(1):183-8. PubMed ID: 6135703
    [No Abstract]   [Full Text] [Related]  

  • 22. Colorimetric determination of nadolol in tablets.
    Ivashikiv E
    J Pharm Sci; 1978 Jul; 67(7):1024-5. PubMed ID: 26790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific and sensitive method for the determination of tobanum using gas chromatography with electron-capture and mass fragmentographic detection.
    Tomori E; Elekes I
    J Chromatogr; 1981 Jan; 204():355-60. PubMed ID: 6111567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of nadolol elimination by activated charcoal and antibiotics.
    du Souich P; Caillé G; Larochelle P
    Clin Pharmacol Ther; 1983 May; 33(5):585-90. PubMed ID: 6839631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and determination of the enantiomers of moprolol and their metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Li F; Bi H; Côté M; Cooper S
    J Chromatogr; 1993 Dec; 622(2):187-95. PubMed ID: 7908669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the analysis of beta-blockers by different techniques.
    Pujos E; Cren-Olivé C; Paisse O; Flament-Waton MM; Grenier-Loustalot MF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4007-14. PubMed ID: 19879818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Feasibility of determining nadolol in serum].
    Surmann P
    Arch Pharm (Weinheim); 1980 Dec; 313(12):1052-4. PubMed ID: 6108753
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of nadolol in healthy subjects.
    Schäfer-Korting M; Bach N; Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1984; 26(1):125-7. PubMed ID: 6714285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capillary gas chromatographic-mass spectrometric study of the effect of solvents on metoprolol and other aryloxypropanolamines.
    Mok V; Bui LV; Chan LT
    J Chromatogr; 1987 May; 393(3):335-42. PubMed ID: 2885334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nadolol binding to human serum proteins.
    Patel L; Johnson A; Turner P
    J Pharm Pharmacol; 1984 Jun; 36(6):414-5. PubMed ID: 6146679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacology and clinical pharmacokinetics of nadolol].
    Lazowski J; Wegrzyn B; Lypka A
    Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of tertatolol enantiomers in biological fluids by high-performance liquid chromatography.
    Lave T; Efthymiopoulos C; Koffel JC; Jung L
    J Chromatogr; 1991 Dec; 572(1-2):203-10. PubMed ID: 1687817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nadolol in human serum and breast milk.
    Devlin RG; Duchin KL; Fleiss PM
    Br J Clin Pharmacol; 1981 Sep; 12(3):393-6. PubMed ID: 6117304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of bucindolol and its major metabolites in plasma by capillary gas chromatography-mass spectrometry.
    Bartek MJ; Kerns EH; Gammans RE; Gallo DG
    J Chromatogr; 1986 Apr; 377():183-94. PubMed ID: 3711207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous screening analysis of multiple beta-blockers in urine by gas chromatography-mass spectrometry in selected ion monitoring mode.
    Paik MJ; Lee J; Kim KR
    Anal Chim Acta; 2007 Oct; 601(2):230-3. PubMed ID: 17920396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous determination of (R)- and (S)-celiprolol in human plasma and urine: high-performance liquid chromatographic assay on a chiral stationary phase with fluorimetric detection.
    Hartmann C; Krauss D; Spahn H; Mutschler E
    J Chromatogr; 1989 Nov; 496(2):387-96. PubMed ID: 2575621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of Some β-Blockers and β2-Agonists in Plasma and Urine Using Liquid Chromatography-tandem Mass Spectrometry and Solid Phase Extraction.
    Salem AA; Wasfi I; Al-Nassib SS; Allawy Mohsin M; Al-Katheeri N
    J Chromatogr Sci; 2017 Sep; 55(8):846-856. PubMed ID: 28633284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periodate oxidimetric determination of nadolol.
    Mohamed ME; Tawakkol MS; Aboul-Enein HY
    Pharmazie; 1981; 36(7):516. PubMed ID: 6269122
    [No Abstract]   [Full Text] [Related]  

  • 40. Selected ion monitoring of metoprolol and two metabolites in plasma and urine using deuterated internal standards.
    Ervik M; Hoffmann KJ; Kylberg-Hanssen K
    Biomed Mass Spectrom; 1981 Jul; 8(7):322-6. PubMed ID: 7284572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.